SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001078782-18-001316
Filing Date
2018-11-14
Accepted
2018-11-14 16:04:18
Documents
34
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT f10q093018_10q.htm 10-Q 264203
2 EXHIBITS 31.1 AND 31.2 SECTION 302 CERTIFICATIONS f10q093018_ex31z1.htm EX-31.1 10607
3 EXHIBITS 32.1 AND 32.2 SECTION 906 CERTIFICATIONS f10q093018_ex32z1.htm EX-32.1 4314
  Complete submission text file 0001078782-18-001316.txt   968562

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT marz-20180930_cal.xml EX-101.CAL 18504
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT marz-20180930_def.xml EX-101.DEF 17420
6 XBRL INSTANCE DOCUMENT marz-20180930.xml EX-101.INS 73259
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT marz-20180930_lab.xml EX-101.LAB 90869
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT marz-20180930_pre.xml EX-101.PRE 71698
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT marz-20180930.xsd EX-101.SCH 13577
Mailing Address 2295 TOWNE LAKE PKWY STE 116-290 WOODSTOCK GA 30189
Business Address 2295 TOWNE LAKE PKWY STE 116-290 WOODSTOCK GA 30189 925-400-3123
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53223 | Film No.: 181183554
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1